Épisodes

  • What's in a Name? The Journey from PCOS to PMOS

    What's in a Name? The Journey from PCOS to PMOS
    Oct 21 2026
    Anuja Dokras, MD, MHCI, PhD, joins Emily O'Brien and new co-host Daniel Edmonston to explain why PCOS is now PMOS, polyendocrine metabolic ovarian syndrome. She traces the global effort behind the new name and how it could reduce stigma, improve frontline care, and open doors to new research funding. https://dcri.org/blog/s3-ep-4-whats-name-journey-pcos-pmos
    Afficher plus Afficher moins
    33 min
  • Beyond the Headlines: AI, Lp(a), Faster Trials, and the Future of Research Funding

    Beyond the Headlines: AI, Lp(a), Faster Trials, and the Future of Research Funding
    Oct 7 2026
    Hosts Manesh Patel and Emily O'Brien look past the headlines on Novartis' Lp(a) drug trial results, AI agents in medicine, the FDA's Operation Trailblazer to speed up clinical trials, Dolly Parton's support for COVID research, and the case for steady NIH funding. https://dcri.org/blog/s3-ep-3-beyond-headlines
    Afficher plus Afficher moins
    26 min
  • The Critical Filling: 30 Years with Harrington, Peterson & Curtis

    The Critical Filling: 30 Years with Harrington, Peterson & Curtis
    Sep 23 2026
    Three former DCRI executive directors, Bob Harrington, Eric Peterson, and Lesley Curtis, join Beyond the Endpoint for part two of the institute's 30th anniversary series. They reflect on growth, crisis, inconvenient truths, and the culture they believe will carry DCRI through whatever comes next. https://dcri.org/blog/s3-ep-2-critical-filling-30-years-harrington-peterson-curtis
    Afficher plus Afficher moins
    36 min
  • The Foundation & the Future: 30 Years with Califf & Hernandez

    The Foundation & the Future: 30 Years with Califf & Hernandez
    Sep 9 2026
    To mark DCRI's 30th anniversary, this first episode in a two-part series features founding director Robert Califf and current Executive Director Adrian Hernandez as they look back at the institute's evolution and ahead to its future. Part two arrives Sept. 23. https://dcri.org/blog/s3-ep-1-foundation-future-30-years-califf-hernandez
    Afficher plus Afficher moins
    36 min
  • Beyond the Headlines: PMDD and Antihistamines, Real-Time FDA Study Monitoring Using Al, and More!

    Beyond the Headlines: PMDD and Antihistamines, Real-Time FDA Study Monitoring Using Al, and More!
    May 13 2026
    In this Beyond the Headlines episode, we examine the FDA's push for real-time clinical trial data, an executive order making psychedelic research a federal priority, advances in CAR T-cell therapy for autoimmune conditions, and viral claims about antihistamines as a treatment for premenstrual dysphoric disorder. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-16-beyond-headlines
    Afficher plus Afficher moins
    25 min
  • The COPD Gap: Diagnosis, Treatment, and Access

    The COPD Gap: Diagnosis, Treatment, and Access
    Apr 22 2026
    COPD is the third leading cause of death worldwide. Yet the disease remains underdiagnosed and underfunded. Host Emily O'Brien and pulmonologist Chris Mosher discuss stigma, funding disparities, barriers to care, and promising research that's bringing new hope to patients. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-15-copd-gap-diagnosis-treatment-and-access
    Afficher plus Afficher moins
    35 min
  • Hard Habits: What Kidney Stones Teach Us About Behavior Change

    Hard Habits: What Kidney Stones Teach Us About Behavior Change
    Apr 8 2026
    Why is it so hard to change our behavior, even when we know what we should be doing? Host Emily O'Brien sits down with urologist and DCRI faculty member Dr. Chuck Scales to discuss the science of behavior change and surprising findings from the PUSH trial, the largest kidney stone prevention trial to date. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-14-hard-habits-what-kidney-stones-teach-us-about-behavior-change
    Afficher plus Afficher moins
    24 min